labet88 download
GSA Capital Partners LLP Sells 11,601 Shares of The ODP Co. (NASDAQ:ODP)
How co-writing a book threatened the Carters' marriage NEW YORK (AP) — No ex-president had a more prolific and diverse publishing career than Jimmy Carter . His more than two dozen books included nonfiction, poetry, fiction, religious meditations and a children’s story. Canadian Press Dec 29, 2024 2:19 PM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message This combination of book cover images shows some of the many books authored by President Jimmy Carter, top row from left, "An Hour Before Daylight: Memories of a Rural Boyhood," "Christmas in Plains: Memories," "The Nobel Peace Prize Lecture," "The Hornet's Nest: A Novel of the Revolutionary War," "Sharing Good Times," "Our Endangered Values: America's Moral Crisis," and "Palestine: Peace Not Apartheid," bottom row from left, "Beyond the White House," "A Remarkable Mother," "We Can Have Peace in the Holy Land: A Plan That Will Work," "White House Diary" (FSG), "A Call to Action: Women, Religion, Violence, and Power," "A Full Life: Reflections at Ninety," and "Faith: A Journey for All." (Simon & Schuster/FSG via AP) NEW YORK (AP) — No ex-president had a more prolific and diverse publishing career than Jimmy Carter . His more than two dozen books included nonfiction, poetry, fiction, religious meditations and a children’s story. His memoir “An Hour Before Daylight” was a Pulitzer Prize finalist in 2002, while his 2006 best-seller “Palestine: Peace Not Apartheid” stirred a fierce debate by likening Israel’s policies in the West Bank to the brutal South African system of racial segregation. And just before his 100th birthday, the Dayton Literary Peace Prize Foundation honored him with a lifetime achievement award for how he wielded "the power of the written word to foster peace, social justice, and global understanding.” In one recent work, “A Full Life,” Carter observed that he “enjoyed writing” and that his books “provided a much-needed source of income.” But some projects were easier than others. “Everything to Gain,” a 1987 collaboration with his wife, Rosalynn, turned into the “worst threat we ever experienced in our marriage,” an intractable standoff for the facilitator of the Camp David accords and winner of the Nobel Peace Prize. According to Carter, Rosalynn was a meticulous author who considered “the resulting sentences as though they have come down from Mount Sinai, carved into stone.” Their memories differed on various events and they fell into “constant arguments.” They were ready to abandon the book and return the advance, until their editor persuaded them to simply divide any disputed passages between them. “In the book, each of these paragraphs is identified by a ‘J’ or an ‘R,’ and our marriage survived,” he wrote. Here is a partial list of books by Carter: “Keeping Faith: Memoirs of a President” “The Blood of Abraham: Insights into the Middle East” (With Rosalynn Carter) “Everything to Gain: Making the Most of the Rest of Your Life” “An Outdoor Journal: Adventures and Reflections” “Turning Point: A Candidate, a State, and a Nation Come of Age” “Always a Reckoning, and Other Poems” (With daughter Amy Carter) “The Little Baby Snoogle-Fleejer” “Living Faith” “The Virtues of Aging” “An Hour Before Daylight: Memories of a Rural Boyhood” “Christmas in Plains: Memories” “The Hornet’s Nest: A Novel of the Revolutionary War” “Our Endangered Values: America’s Moral Crisis” “Faith & Freedom: The Christian Challenge for the World” “Palestine: Peace Not Apartheid” “A Remarkable Mother” “Beyond the White House” “We Can Have Peace in the Holy Land: A Plan That Will Work” “White House Diary” “NIV Lessons from Life Bible: Personal Reflections with Jimmy Carter” “A Call to Action: Women, Religion, Violence, and Power” “A Full Life: Reflections at Ninety” The Associated Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message More Entertainment News Charles Shyer, ‘Father of the Bride’ and ‘Baby Boom’ filmmaker, dies at 83 Dec 29, 2024 2:26 PM 'Sonic 3' and 'Mufasa' battle for No. 1 at the holiday box office Dec 29, 2024 9:55 AM 'Sonic 3' and 'Mufasa' battle for No. 1 at the holiday box office Dec 29, 2024 9:02 AM Featured Flyer
Kandace Espinosa Sworn in as White Settlement City Councilmember; Gregg Geesa Appointed to Planning and Zoning BoardVancouver fans will enjoy 5G network upgrades at BC PlaceBulls vs. Hornets Injury Report Today – December 13
B. Riley Issues Pessimistic Forecast for Oaktree Specialty Lending (NASDAQ:OCSL) Stock Price
Corhen 7-11 0-0 14, G.Diaz Graham 1-3 0-0 2, Dunn 1-3 0-0 2, Leggett 6-14 8-9 21, Lowe 6-13 6-7 22, Cummings 1-5 0-0 3, Austin 2-5 5-6 10. Totals 24-54 19-22 74. R.Miller 0-2 0-0 0, Reed 6-10 1-4 14, Bailey 3-6 0-0 6, Carter 3-12 5-7 11, Sears 2-8 0-0 5, V.Miller 3-6 6-7 14, Givens 1-4 0-0 2, Chest 3-7 0-0 6, Fountain 1-2 0-0 3, Collins 0-2 2-2 2. Totals 22-59 14-20 63. Halftime_LSU 28-27. 3-Point Goals_Pittsburgh 7-24 (Lowe 4-7, Austin 1-4, Cummings 1-5, Leggett 1-5, Corhen 0-1, G.Diaz Graham 0-2), LSU 5-21 (V.Miller 2-3, Fountain 1-1, Reed 1-1, Sears 1-4, Collins 0-1, R.Miller 0-1, Givens 0-2, Bailey 0-3, Carter 0-5). Fouled Out_Dunn. Rebounds_Pittsburgh 32 (Lowe 8), LSU 30 (Chest 8). Assists_Pittsburgh 13 (Lowe 6), LSU 9 (Bailey, Carter, Sears, Givens 2). Total Fouls_Pittsburgh 20, LSU 20. A_1,112 (2,000).
Detroit Red Wings (8-10-2, in the Atlantic Division) vs. New York Islanders (8-8-5, in the Metropolitan Division) Elmont, New York; Monday, 7:30 p.m. EST BOTTOM LINE: The New York Islanders host the Detroit Red Wings after Kyle Palmieri scored two goals in the Islanders' 3-1 win against the St. Louis Blues. New York has an 8-8-5 record overall and a 3-3-2 record in home games. The Islanders have a 2-3-1 record when they commit more penalties than their opponent. Detroit is 8-10-2 overall and 4-5-1 on the road. The Red Wings have gone 3-3-2 in games their opponents serve fewer penalty minutes. The teams meet Monday for the third time this season. The Red Wings won the last meeting 2-1. TOP PERFORMERS: Bo Horvat has five goals and nine assists for the Islanders. Maxim Tsyplakov has over the last 10 games. Alex DeBrincat has eight goals and nine assists for the Red Wings. Albert Johansson has over the past 10 games. LAST 10 GAMES: Islanders: 4-3-3, averaging 2.7 goals, 4.7 assists, 2.6 penalties and 5.5 penalty minutes while giving up 2.6 goals per game. Red Wings: 4-5-1, averaging 2.2 goals, 3.5 assists, 2.2 penalties and 4.4 penalty minutes while giving up 2.5 goals per game. INJURIES: Islanders: None listed. Red Wings: None listed. ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar . The Associated PressJimmy Carter’s public service heralded by Southern California lawmakers on either side of the aisleIslanders host the Red Wings after Palmieri’s 2-goal game
TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based regenerative therapies, has announced significant findings from an expanded preclinical study of the potential of its portfolio drug, ExoPTEN, for repairing optic nerve damage. Conducted in collaboration with the Goldschleger Eye Institute at Sheba Medical Center, consistently ranked one of the top ten hospitals in the world 1 , the study builds on previously announced preliminary results 2 on June 28, 2024 and strengthens the suggestion of a promising treatment pathway for glaucoma, the leading cause of irreversible blindness globally 3 . The Optic Nerve Disorders treatment market is expected to grow from 5.54 (USD Billion) in 2023 to 11.5 (USD Billion) by 2032, at a compound annual growth rate (CAGR) of ~8.46% during the forecast period 4 . Researchers utilized a rodent model of optic nerve crush (ONC) to simulate the damage associated with conditions like glaucoma. After inducing injury, ExoPTEN was administrated via direct injection into the eyes. The study expanded on earlier findings which indicated that eyes treated with ExoPTEN regained nearly normal retinal activity, as evidenced by electrical tests. Expanded analyses of the study data showed clear recovery of signal transmission in treated eyes compared to untreated controls, which showed no significant response. Additionally, imaging results by optical coherence tomography (OCT) scans indicates and validates that in all of treated eyes (naïve exosome treatment or ExoPTEN treatment) a successful ONC procedure has been performed (Figure 1). The study also showed that ExoPTEN treatment significantly enhanced the survival of retinal ganglion cells - key neurons responsible for transmitting visual information to the brain. Detailed analysis of retinal flat-mounts confirmed this effect, with treated eyes exhibiting substantially higher counts of these cells compared to untreated or control-treated eyes (Figures 2A and 2B). Dr. Ifat Sher, the lead investigator from the Goldschleger Eye Institute, commented, “the results from this expanded study are extremely encouraging. ExoPTEN demonstrates potential as a treatment that restores functionality and offers neuroprotection. The study shows clear signal recovery, healthier optic nerve structures and preserved retinal ganglion cells. These results suggest that ExoPTEN could fundamentally change how we approach conditions like glaucoma and optic nerve trauma. Encouraged by these results, we are advancing to a larger study with more animals to validate and expand upon these findings.” Dr. Lior Shaltiel, CEO of NurExone, added, “these findings are an important step forward in our mission to develop groundbreaking therapies for regenerative medicine in several indications. ExoPTEN’s ability to repair both the structure and function of the optic nerve highlights its transformative potential for addressing vision loss and improving tens of millions of patient lives.” About NurExone NurExone Biologic Inc. is a TSX Venture Exchange (“ TSXV ”) and OTCQB listed pharmaceutical company that is developing a platform for biologically guided exosome-based therapies to be delivered, minimally-invasively, to patients who have suffered Central Nervous System injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, was proven to recover motor function in 75% of laboratory rats when administered intranasally. ExoPTEN has been granted Orphan Drug Designation by the United States Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). The NurExone platform technology is expected to offer novel solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. For additional information and a brief interview, please watch Who is NurExone? , visit www.nurexone.com or follow NurExone on LinkedIn , X (formerly Twitter) , Facebook or YouTube Dr. Lior Shaltiel Chief Executive Officer and Director Phone: +972-52-4803034 Email: info@nurexone.com Oak Hill Financial Inc. 2 Bloor Street, Suite 2900 Toronto, Ontario M4W 3E2 Investor Relations - Canada Phone: +1-647-479-5803 Email: info@oakhillfinancial.ca Dr. Eva Reuter Investor Relations - Germany Phone: +49-69-1532-5857 Email: e.reuter@dr-reuter.eu Allele Capital Partners Investor Relations - US Phone: +1 978-857-5075 Email: aeriksen@allelecapital.com FORWARD-LOOKING STATEMENTS This press release contains certain “forward-looking statements” that reflect the Company’s current expectations and projections about its future results. Wherever possible, words such as “may”, “will”, “should”, “could”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict” or “potential” or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements relating to: the results of the Company’s preclinical trials and its suggestion of a promising treatment pathway for glaucoma; the growth of the Optic Nerve Disorders treatment market; the Company expanding to further studies; the Company developing groundbreaking therapies for regenerative medicine in several indications; ExoPTEN having the potential to address vision loss and improve patient lives; and the NurExone platform technology offering novel solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. These statements reflect management’s current beliefs and are based on information currently available to management as at the date hereof. In developing the forward-looking statements in this press release, we have applied several material assumptions, including : the a bility to carry out its pre-clinical trials and realize upon the stated benefits of the pre-clinical trials; the Company’s ability to realize upon the stated potential for exosome-loaded drugs in regenerating or repairing damaged nerves; the Company’s ability to maintain its ongoing commitment to using its ExoTherapy platform to advance the field of regenerative medicine; the Optic Nerve Disorders treatment market continuing to grow as stated; the Company expanding to further studies; the Company developing groundbreaking therapies for regenerative medicine in several indications; ExoPTEN addressing vision loss and improve patient lives; and the NurExone platform technology will offer novel solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These risks and uncertainties include, but are not limited to risks related to : the Company’s early stage of development; lack of revenues to date; government regulation; market acceptance for its products; rapid technological change; dependence on key personnel; dependence on the Company’s strategic partners; the fact that preclinical drug development is uncertain, and the drug product candidates of the Company may never advance to clinical trials; the fact that results of preclinical studies and early-stage clinical trials may not be predictive of the results of later stage clinical trials; the uncertain outcome, cost, and timing of product development activities, preclinical studies and clinical trials of the Company; the uncertain clinical development process, including the risk that clinical trials may not have an effective design or generate positive results; the potential inability to obtain or maintain regulatory approval of the drug product candidates of the Company; the introduction of competing drugs that are safer, more effective or less expensive than, or otherwise superior to, the drug product candidates of the Company; the initiation, conduct, and completion of preclinical studies and clinical trials may be delayed, adversely affected or impacted by unforeseen issues; the potential inability to obtain adequate financing; the potential inability to obtain or maintain intellectual property protection for the drug product candidates of the Company; risks that the Company’s intellectual property and technology won’t have the intended impact on the Company and/or its business; the Company’s inability to carry out its pre-clinical trials and realize upon the stated benefits of the pre-clinical trials; the Company’s inability to realize upon the stated potential for exosome-loaded drugs in regenerating or repairing damaged nerves; the Company’s inability to maintain its ongoing commitment to using its ExoTherapy platform to advance the field of regenerative medicine; the Optic Nerve Disorders treatment market decreasing and/or plateauing ; the Company ’s inability to expand into further studies; the NurExone platform technology not offering novel solutions to drug companies interested in minimally invasive targeted drug delivery for other indications ; and the risks discussed under the heading “Risk Factors” on pages 44 to 51 of the Company’s Annual Information Form dated August 27 , 202 4 , a copy of which is available under the Company’s SEDAR+ profile at www.sedarplus.ca . These factors should be considered carefully, and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, the Company cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law. Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. 1 https://www.afsmc.org/2024/02/sheba-medical-center-named-a-newsweek-worlds-best-hospital-for-the-6th-consecutive-year/ 2 https://www.globenewswire.com/news-release/2024/06/28/2906122/0/en/NurExone-s-ExoPTEN-Being-Studied-as-Glaucoma-Treatment-for-US-3-4-Billion-Market.html 3 https://www.mdpi.com/1424-8247/17/10/1261 4 https://www.marketresearchfuture.com/reports/optic-nerve-disorders-treatment-market-30051 A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5e682a60-3287-44b2-b7da-08ebed8fa807Newsquest will not reveal the details of which two celebrities found themselves in the bottom two since these results have not been verified (and to not spoil tonight's programme). During last night’s show (November 23), two couples found themselves at the top of the leaderboard, with the combined scores from their dance routines and points from the Samba-Thon. JLS star JB Gill and Love Island favourite Tasha Ghouri (along with their professional dance partners) ended the night with a score of 46 each. During their lively Charleston to Yes Sir! That’s My Baby by Firehouse Five Plus Two, JB flipped Lauren Oakley upside down and in a cartwheel spin and showed off his quick footwork before completing a series of dramatic lifts. Head judge Shirley Ballas thanked JB for bringing “so much joy” to the dance floor, while Craig Revel Horwood praised the routine as “pure class”. As the results show for Strictly is filmed on the same night as the rest of the show, but broadcast a day later, it allows people who are in the crowd for filming to know who is eliminated ahead of time. Due to this, the results were leaked on social media late last night and those who found out which celebrity left in week 10 “gasped” and claimed "wrong person to go". A post shared by BBC Strictly (@bbcstrictly) This person wrote on X: “oh i GASPED that’s so insane???” “No way what the hell,” tweeted another. “Shocked !! What the hell,” shared this account. Someone else added: “Noooo omg wrong person to go.” One fan posted: “Neither should have been in dance off. That's a shame.” Recommended reading: In agreement, a viewer commented: “Disgraceful neither should have been there!!!!” Others said they were “gutted for them” and “no way...this is a joke!!” The Strictly Come Dancing result show will air on Sunday, November 24 on BBC One and iPlayer at 7.20pm.
Corning Inc. stock underperforms Friday when compared to competitors
MISSOULA — The Montana women's basketball team ran into a buzzsaw Sunday in defensive-minded Big Ten foe Minnesota. The Golden Gophers held the Lady Griz to a season-low seven points in the first quarter in racing to a 22-point lead. From there unbeaten Minnesota cruised to an 84-45 win at Williams Arena in Minneapolis. Montana had a two-game win streak snapped in falling to 3-3. Minnesota, who held UMass-Lowell and Oregon State in the 30s in wins earlier this season, improved to 7-0. The Gophers are coached by former South Dakota skipper Dawn Plitzuweit, whose emphasis on defense has been well-received. Minnesota finished 20-16 in her first season and is off to an impressive start this year. Not only did Montana lose the game, the team may have lost redshirt freshman guard Macy Donarski for a while. She left the game in the first quarter with what looked to be a significant left leg injury. Donarski did not play last season due to a knee injury. Montana was befuddled from the start by the Gophers' defense. Minnesota stresses team defense with active rotations and an emphasis on forcing turnovers. The Lady Griz had 16 turnovers in the game Montana hit just 3 of 12 shots in the first quarter in spotting the hosts a gaudy 29-7 lead. Minnesota was 9 for 19 with two triples. The Gophers stretched their lead to 52-22 by halftime. The Lady Griz were 7 for 23 from the floor. Mack Konig and Adria Lincoln were bright spots with nine points apiece in the first 20 minutes. Minnesota continued to add to its lead in the second half. The Gophers led by as many as 40 points in the fourth quarter before settling for their 39-point victory. Montana's seven points in first quarter were a season low. The Lady Griz had the same total in the fourth frame. Bill Speltz is Missoulian sports editor. Contact him at bill.speltz@406mtsports.com or on Twitter @billspeltz Be the first to know Get local news delivered to your inbox! Sports Editor {{description}} Email notifications are only sent once a day, and only if there are new matching items.BUFFALO — The year started with a bang. In January, Gov. Kathy Hochul named UB the home of Empire AI, a new $400 million supercomputing center that will provide UB and partners with breathtakingly powerful resources to harness artificial intelligence for the betterment of society. An avalanche of advancements – all pointing towards UB’s leadership in AI, in New York State and nationwide – followed the governor’s announcement. With interest in AI surging globally, these advancements showcase and build upon UB’s impressive half-century of expertise in AI research and education. They also hint at a brighter future, where AI’s uncanny abilities merge with human ingenuity to tackle society’s greatest challenges. “Traditionally, colleges and universities are at the epicenter of life-changing research and ideas,” said Venu Govindaraju, vice president for research and economic development. “The University at Buffalo is pushing the boundaries of artificial intelligence and data science in fields that are critical to the state’s and nation’s future.” As 2024 comes to a close, here’s a look back at what has been a year of AI at UB. January UB researchers have been laying the groundwork for today’s boom in artificial intelligence for decades. This includes pioneering work creating the world’s first autonomous handwriting recognition system, which the U.S. Postal Service and Royal Mail adopted to save billions of dollars. Those innovations explain, in part, why Gov. Kathy Hochul chose UB to be the home of Empire AI, a consortium of public and private universities, and foundations, that will harness AI for the public good while driving economic development. “We want to make sure New York State is the capital of AI development ... but I need a home for this supercomputer that’ll power the innovation all over our state. And I’m proud to announce that the home will be right here at [UB],” Hochul said Jan. 26 at the Center for the Arts. Earlier in the month, during her State of the State address in Albany, the governor spotlighted UB student Holliday Sims for her work using AI to improve the child welfare system. February UB was chosen to join the federal government’s first-ever consortium dedicated to ensuring that AI systems are safe and trustworthy. Announced Feb. 8, the U.S. AI Safety Institute Consortium (AISIC) includes government agencies and top research universities, as well as Microsoft, Apple, Google, OpenAI and other tech companies. AISIC will create standards for AI usage that protect Americans’ privacy; advance equity and civil rights; and promote innovation and competition. Weeks later, UB was among 28 new members to join AI Alliance, an international coalition led by IBM and Meta that is dedicated to promoting open, safe and responsible AI. March On a beautiful spring day, engineering professor Chase Murray and students took to the skies at UB’s Structure for Outdoor Autonomy Research, one of the largest outdoor drone-testing labs among the nation’s colleges and universities. Murray uses AI and other technologies to optimize how autonomous vehicles work together – research that has implications in logistics, search-and-rescue, surveillance and more. Elsewhere, researchers in UB’s Institute for Artificial Intelligence and Data Science kept tabs on their AI system that aims to improve indoor farming and address food insecurity. And another research group began using AI to make algae fuel production more cost-effective. The projects illustrate UB’s commitment to sustainability and social justice. April April brought Senate Majority Leader Charles Schumer and Sethuraman Panchanathan, director of the National Science Foundation, to campus. The occasion? “Today, we’re here to celebrate something truly amazing: the opening of the new, $20 million, federally funded National AI Institute for Exceptional Education, and it’s going to be housed right here at UB,” said Schumer. Funded by the NSF and Department of Education, the institute will create AI systems that ensure children with speech and language disorders receive timely, effective assistance. The work, which addresses the nationwide shortage of speech-language pathologists, will help ensure that millions of children do not fall behind in their academic and socio-emotional development. May On May 31, UB hosted thought leaders from IBM, M&T Bank, Moog and other institutions for its ongoing chat series on AI and society. “Don’t be an AI user, be an AI value creator,” Dario Gil, IBM senior vice president and director of research, told attendees at the Center of Excellence in Bioinformatics and Life Sciences. The event included presentations from UB researchers using AI to make advancements in medicine, medical devices, climate change, materials science, pharmaceutical science and other fields. June An electricity grid that uses AI to identify and fix problems before they cause widespread power outages? It could become reality sooner than you think due to research published June 4 and co-led by Souma Chowdhury, who studies how to apply AI to complex systems. He is among more than 200 researchers at UB using AI to address societal challenges. Also in June, more than 300 scholars from the Association for the Advancement of Artificial Intelligence, one of the world’s most recognized scientific organizations dedicated to advancing AI research, gathered at UB for a multiday conference. The scholars represented more than a dozen fields – including machine learning, psychology, political science, the humanities and more. July On July 17, SUNY Chancellor John B. King Jr. and state lawmakers visited UB for a roundtable discussion on AI. The attendees learned about UB researchers using AI to identify “forever chemicals,” as well as spinoff companies working on technology to improve treatment for strokes and aneurysms. “We are pioneering AI discoveries that will drive progress in research and economic development, demonstrating UB’s commitment to leveraging technology for societal benefit,” Govindaraju said. August The start of the new semester brought record enrollment to UB’s Master of Science program focusing on AI. Launched in 2020 with five students, the number swelled to 73 students this fall, with an additional 50 expected next semester. The program’s growth “shows that we’re providing students with in-demand skills that they can use for the betterment of society,” said Kemper E. Lewis, dean of the School of Engineering and Applied Sciences. Graduates have taken jobs at Amazon Web Services, NVIDIA, Visa and other companies. September UB was awarded $10 million from the U.S. Department of Education to establish the Center for Early Literacy and Responsible AI. The center will create AI tools to ensure culturally and linguistically diverse learners in grades K-2, including those in Western New York, receive transformative early literacy instruction. “We believe that, with the right support, all students — regardless of their backgrounds — can succeed in literacy,” says project leader X. Christine Wang, a professor of learning and instruction in the Graduate School of Education. Later in the month, Rep. Tim Kennedy announced UB would receive $475,000 to equip its wind tunnel with equipment that allows it to leverage the power of AI, among other technologies. UB uses the facility to study and improve the nation’s response to hurricanes, wildfires and other extreme weather. October On Oct. 11, roughly nine months after it was announced, Empire AI went live. Gov. Kathy Hochul flipped the switch on a stack of powerful new computer servers at Center of Excellence in Bioinformatics and Life Sciences. The servers represent a fraction of the eventual power of Empire AI, which will be located at a new building on North Campus. On the same day, UB President Satish K. Tripathi delivered his annual State of the University address. “While today, only the private sector has the computing power needed to seriously advance AI research, Empire AI will put New York State at the epicenter of artificial intelligence innovation. This game-changing initiative will enable us to tap the full power of AI to solve complex issues facing our state, nation and world.” November From fake celebrity endorsements to manipulated videos of politicians, the 2024 election was rife with misleading information. Debunking much of this content was the DeepFake-o-Meter, a publicly available tool used by journalists, law enforcement and others. The tool was created by UB computer scientist Siwei Lyu and students. With AI being added to medical devices, the Food and Drug Administration wants to ensure these products meet public health standards. The agency called upon experts, including UB’s Peter Elkin, for insight at a public meeting. Elkin, professor and chair of the Department of Bioinformatics, said the FDA should allow these devices to learn and therefore improve. “AI-enabled devices are no longer just tools; now they are partners in care,” he said. Back on campus, UB hosted the latest in a series of “AI at UB” forums on Nov. 21. Organizers updated faculty and staff on how UB is implementing AI in its classrooms and labs. Presenters also discussed how AI can be a tool to foster collaboration and enhance learning outcomes. December In early December, UB officials detailed plans to create a new academic department focused on AI and its impact on society. The department aligns with the mission of UB and SUNY, both of which are committed to responsibly harnessing the power of AI for social good. Around the same time, UB computer scientist Nalini Ratha published a series of research papers focused on machine learning and encrypted data. One of the papers suggests a new technique for safeguarding personal medical data as it travels from third-party cloud service providers back to patients and their doctors. The work points to a future where medical diagnostics are quicker and more accurate, and patient medical records remain confidential.